![Istvan Toth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Peter Devine | M | - |
Neurotide Pty Ltd.
![]() Neurotide Pty Ltd. Pharmaceuticals: MajorHealth Technology Neurotide is a spin-off company from The University of Queensland's commercial arm, UniQuest Pty Ltd. The company's research is led by UQ's Professor Istvan Toth and Dr Joanne Blanchfield, who are creating an oral pharmaceutical for pain. They are demonstrating that the drug can relieve pain in vivo. If this research is successful, the company will move towards human trials. Investors are sought to help them continue development. They hope to access the international market for pain drugs, and are particularly targeting the neuropathic pain market. | - |
Stephen Denaro | M | - |
Neurotide Pty Ltd.
![]() Neurotide Pty Ltd. Pharmaceuticals: MajorHealth Technology Neurotide is a spin-off company from The University of Queensland's commercial arm, UniQuest Pty Ltd. The company's research is led by UQ's Professor Istvan Toth and Dr Joanne Blanchfield, who are creating an oral pharmaceutical for pain. They are demonstrating that the drug can relieve pain in vivo. If this research is successful, the company will move towards human trials. Investors are sought to help them continue development. They hope to access the international market for pain drugs, and are particularly targeting the neuropathic pain market. | - |
Don Kakuda | M | - |
Neurotide Pty Ltd.
![]() Neurotide Pty Ltd. Pharmaceuticals: MajorHealth Technology Neurotide is a spin-off company from The University of Queensland's commercial arm, UniQuest Pty Ltd. The company's research is led by UQ's Professor Istvan Toth and Dr Joanne Blanchfield, who are creating an oral pharmaceutical for pain. They are demonstrating that the drug can relieve pain in vivo. If this research is successful, the company will move towards human trials. Investors are sought to help them continue development. They hope to access the international market for pain drugs, and are particularly targeting the neuropathic pain market. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
Pays | Relations | % du total |
---|---|---|
Australie | 3 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Istvan Toth
- Réseau Personnel